Screener
Amphastar Pharmaceuticals AMPH Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 630,951 | 636,016 |
| Property, plant, and equipment, net | 316,063 | 310,567 |
| Finance lease right-of-use assets | 152 | 221 |
| Operating lease right-of-use assets | 72,911 | 42,931 |
| Goodwill and intangible assets, net | 647,833 | 565,965 |
| Other assets | 33,392 | 31,135 |
| Deferred tax assets | 42,464 | 42,464 |
| Total assets | $1,743,766 | $1,629,299 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Amphastar Pharmaceuticals's operating lease ROU assets?
- Amphastar Pharmaceuticals (AMPH) reported operating lease ROU assets of $72.91M in Q2 2026.
- How has Amphastar Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Amphastar Pharmaceuticals's operating lease ROU assets increased by 65.0% year-over-year, from $44.2M to $72.91M.
- What is the long-term trend for Amphastar Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's operating lease ROU assets has grown at a 16.5% compound annual growth rate (CAGR), from $20.04M to $42.93M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Amphastar Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude